Gender differences in the prevalence of hypertension in a representative sample of iranian population: The Isfahan healthy heart program

Acta Biomedica

Volumn 82, Issue 3, 2011, Pages 223-229

  Shirani, Shahin ^a   Gharipour, Mojgan ^a   Khosravi, Alireza ^a   Kelishadi, Roya ^a   Habibi, Hamid Reza ^a   Abdalvand, Ali ^a   Sarrafzadegan, Nizal ^a  

^a Isfahan Cardiovscular Research Center   (Iran)

Author keywords

Blood pressure; Hypertension; Isfahan healthy heart program

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; COMMUNITY SAMPLE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; IRAN; MALE; PREVALENCE; RURAL POPULATION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TREND STUDY; URBAN POPULATION;

ADULT; FEMALE; HUMANS; HYPERTENSION; IRAN; MALE; MIDDLE AGED; PREVALENCE; RURAL POPULATION; URBAN POPULATION; YOUNG ADULT;

EID: 84860813228     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. August P, Oparil S. Hypertension in women. J Clin Endocrinol Metabolism 1999; 84 (6): 1862-66.
2. Oza S, Danaei G, Murray C. High blood pressure worsening in all states for women; begins to stagnate for men. American Heart Association rapid access journal report, 2008.
3. Caulin-Glaser T. Primary prevention of hypertension in women. J Clin Hypertens (Greenwich) 2000; 2 (3): 204-9.
4. Safar ME, Smulyan H. Hypertension in Women. AJH 2004; 17 (1): 82-7.
5. Nichols WW, O'Rourke MF. Wave reflections, in McDonald's Blood Flow in Arteries, 4th ed. New York, Oxford University Press, 1998, pp 214-222.
6. Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med 2001; 4: 10-13.
7. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
8. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health 1994; 84: 1768-774.
9. Shirani S, Kelishadi R, Sarrafzadegan N, et al. Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study. East Mediterr Health J 2009; 15 (6): 1455-63.
10. Sarraf-Zadegan N, Sadri G, Malek Afzali H, et al. Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol 2003; 58 (4): 309-20.
11. Rabiei K, Kelishadi R, Sarrafzadegan N, et al. Process evaluation of a community-based program for prevention and control of non-communicable disease in a developing country: The Isfahan Healthy Heart Program, Iran. BMC Public Health 2009; 9: 57.
12. Sarrafzadegan N, Baghaei A, Sadri G. et al. Isfahan healthy heart program: evaluation of comprehensive, communitybased interventions for non-communicable disease prevention. Prevention and Control 2006; 2 (2): 73-84.
13. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17 (2): 151-83.
14. Furumoto-Dawson AA, Pandey DK, Elliott WJ, et al. Hypertension in women: the Women Take Heart project. J Clin Hypertens (Greenwich) 2003; 5 (1): 38-46.
15. Wenger NK. Hypertension and other cardiovascular risk factors in women. Am J Hypertens 1995; 8 (12 Pt 2): 94-9.
16. Ghannem H, Hadj Fredj A. Epidemiology of hypertension and other cardiovascular disease risk factors in the urban population of Soussa, Tunisia. Eastern Mediterranean Health Journal 1997; 3 (3): 472-9.
17. Yong LC, Kuller LH, Rutan G, Bunker C. Longitudinal study of blood pressure changes and determinants from adolescence to middle age. The Dormont High School Follow-Up Study, 1957-1963 to 1989-1990. Am J Epidemiol 1993; 138: 973-83.
18. Stamler J, Stamler R, Riedlinger WF, Algera G, Roberts RH. Hypertension screening of 1 milion Americans. Community Hypertension Evaluation Clinic (CHEC) Program, 1973-1975. JAMA 1976; 235: 2299-306.
19. Vokonas PS, Kannel WB, Cupples LA. 1988 Epidemioilogy and risk of hypertension in the elderly:The Framingham Study. J Hypertens 1988; 6: 3-9.
20. Smulyan H, Asmar RG, Rudnicki A, London GM, Safar ME. Comparative effects of aging in men and women on the properties of the arterial tree. J Am Coll Cardiol 2001; 37: 1374-80.
21. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865-72.
22. Chapman AB, Zamudio S, Woodmansee W, et al. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol 1997, 273: F777-F782.
23. Gruppo di Studio Progetto Menopausa Italia. Risk factors for high blood pressure in women attending menopause clinics in Italy. Maturitas 2006; 10; 53(1): 83-8.
24. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-13.
25. Minh HV, Byass P, Chuc NT, Wall S. Gender differences in prevalence and socioeconomic determinants of hypertension: findings from the WHO STEPs survey in a rural community of Vietnam. J Hum Hypertens 2006; 20 (2): 109-15.
26. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594-9.
27. Lloyd-Jones DM. Epidemiology of hypertension in the old data from the community in the 1990S. AJH 2005; 17 (5). Part two.
28. Frazier CG, Shah SH, Armstrong PW, et al. The SYMPHONY and the Second SYMPHONY Investigators. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: Observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials. Am Heart J 2005; 150: 1260-7.
29. Kaplan NM. The treatment of hypertension in women. Arch Intern Med 1995; 27; 155 (6): 563-7.
30. Krakoff LR. Hypertension in women: progress and unsolved problems. Women Health 1985; 10 (2-3): 75-83.
31. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28: 576-582.
32. Lewis CE. Characteristics and treatment of hypertension in women: a review of the literature. Am J Med Sci 1996; 311 (4): 193-9.